Skip to main content
FinSpry Logo
FinSpry
MIRM logo
MIRM
(NASDAQ)
Mirum Pharmaceuticals, Inc.
$114.36-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Mirum Pharmaceuticals (MIRM) Stock Price & Financial Analysis

Mirum Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$116.12 - $120.54
52-Week High$130.00
52-Week Low$50.25
Open$118.95
Volume365.74K
Average Volume (3M)908.63K
Market Cap6.86B
Shares Outstanding58.85M
Price to Sales (P/S)12.13
Price to Book (P/B)28.48
EV/EBITDA-9.07
Revenue (TTM)569.61M
Net Income (TTM)-798.84M
Free Cash Flow (TTM)-172.55M
EPS (TTM)$-14.81
Profit Margin-140.24%
Operating Margin-12.31%
Return on Equity (ROE)-329.43%
Debt to Equity1.34
50-Day MA$107.75
200-Day MA$90.51
52-Week Change122.57%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Mirum Pharmaceuticals

What is the current stock price for MIRM?

As of the latest trading session, MIRM stock trades at $116.62. The 52-week range is $50.25–$130.00, with a day range of $116.12–$120.54.

What is the P/E ratio for MIRM?

The P/E ratio (Price-to-Earnings) for MIRM is shown in the Key Statistics section. This valuation metric helps compare Mirum Pharmaceuticals, Inc. to industry peers.

Does MIRM pay dividends?

Mirum Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MIRM?

Based on 17 analysts, the consensus for MIRM is Buy.

What is the market cap of MIRM?

Mirum Pharmaceuticals's market capitalization is $6.86B, classifying it as a mid-cap company. Mirum Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.